ABSTRACT. We conducted a study to investigate the role of three IL-17 gene single nucleotide polymorphisms (SNP) (rs2275913G>A, rs3748067C>T, and rs763780 T>C) in the development of gastric cancer. A total of 252 patients with gastric cancer and 252 control subjects were collected between May 2012 and May 2014. The SNP genotyping of IL-17A rs2275913G>A and rs3748067C>T and IL-17F rs763780 T>C was performed using the Sequenom MassARRAY platform (Sequenom, San Diego, CA, USA) according to the manufacturer instructions. By conditional regression analysis, individuals carrying the AA and the GA+AA genotypes of rs2275913G>A were correlated with an elevated risk of gastric cancer when compared with those carrying the GG genotype, and the adjusted ORs (95%CIs) were 2.05 (1.13-3.76) for the AA genotype and 1.45 (1.03-2.08) for the GA+AA genotype. In conclusion, our results suggest that the IL-17A rs3748067C>T and IL-17F rs763780 T>C polymorphisms play an important role in the risk of gastric cancer in a Chinese population.
INTRODUCTION
Gastric cancer (GC) is the fourth most common cancer in the world and the second most common cause of cancer-related death (International Agency for Research on Cancer, 2012) . Although genetic and environmental factors in addition to Helicobacter pylori infections have been identified as playing important roles in the development of GC (Houghton and Wang, 2005; Merchant, 2005; Dong et al., 2008) , the precise etiology of the disease remains unclear.
Chronic inflammation is a well-known risk factor for malignant transformation, but the role inflammation plays in cancer initiation is poorly understood (Scheller et al., 2006; Candido and Hagemann, 2013) . Interleukin-17 (IL-17) is a novel cytokine family that consists of six protein members (IL-17A-F) that play important roles in many chronic inflammatory diseases and in cancer development (Wu et al., 2013) . Several previous studies have reported that the over-expression of IL-17A and IL-17F could be found in various tumor tissues such as breast cancer, GC, and nonsmall cell lung cancer (Meng et al., 2012; Yang et al., 2012; Cheng et al., 2015) . Single nucleotide polymorphisms (SNPs) are an important type of gene mutation that can influence the transcription and translation of the associated gene. Previous studies have reported an association between IL-17 gene polymorphisms and the risk of GC, but the results have been inconsistent (Qinghai et al., 2014; Wang et al., 2014; Yu et al., 2014; Gao et al., 2015) . We therefore conducted a study to investigate the role of 3 SNPs in IL-17 (rs2275913G>A, rs3748067C>T, and rs763780 T>C) in the development of GC.
MATERIAL AND METHODS

Patients
A total of 252 patients with GC and 252 control subjects were collected from Zhengzhou People's Hospital between May 2012 and May 2014. All patients with GC were histopathologically confirmed. The exclusion criteria were the presence of any other malignant tumors or inadequate organ function. To obtain frequency-matched controls on age and gender, 252 control subjects were randomly selected from the Health Check-up Center of the Zhengzhou People's Hospital during the same period. Control subjects who had a history of cancer were excluded from our study.
Demographic and related lifestyle factors of patients with GC and control subjects were collected using a face-to-face questionnaire and included gender, age, dietary habits, alcohol consumption, tobacco smoking, and family history of cancer.
Enzyme-linked immunoabsorbent assay (ELISA) (Diagnostic Automation, USA) and a rapid urea breath test were performed to assess the H. pylori infection state of patients with GC and controls.
Informed consent was obtained from all patients and control subjects or their relatives before enrollment in this study. The study protocol was approved by the Ethics Committee of Zhengzhou People's Hospital. genomic DNA extraction. The blood samples were kept at -20°C until use, with 0.5 mg/mL ethylenediaminetetraacetic acid used as an anticoagulant. Samples were placed randomly onto 384-well plates and were blinded for disease status. The design of the assay and the SNP genotyping of IL-17A rs2275913G>A and rs3748067C>T and IL-17F rs763780 T>C were performed by Bio Miao Biological Technology (Beijing, China) using the Sequenom MassARRAY platform (Sequenom, San Diego, CA, USA) according to the manufacturer instructions. The results of all duplicated samples were 100% consistent.
Statistical analysis
The chi-square (χ 2 ) test was used to compare the differences in gender, age, dietary habits, alcohol consumption, tobacco smoking, and family history of cancer, and also the frequency distributions of genotypes and alleles between patients and controls. A χ 2 was taken to evaluate the Hardy-Weinberg equilibrium (HWE) of the control groups. Unconditional logistic regression analysis was performed to calculate ORs and 95%CIs as estimates of the relative risk for each SNP, with adjustment for potential confounding factors. The most common genotype in the controls was used as the reference group. All P values were two-sided, and a P value < 0.05 was considered to be statistically significant. The SPSS 16.0 (SPSS, Inc, Chicago, IL, USA) software was used for statistical analyses.
RESULTS
Demographic and clinical characteristics of patients with GC and control subjects are summarized in Table 1 . The mean ages of patients with GC and control subjects were 57.72 ± 10.75 and 58.25 ± 11.25 years, respectively. As expected, there were no significant differences in gender and age between patients and control subjects (P > 0.05). We found that patients with GC were more likely to be alcohol drinkers, have cancer history in the first relatives, and be infected with H. pylori. In our study population, the genotype and allele distributions of IL-17A rs2275913G>A conformed to HWE in the control group, while those of IL-17A rs3748067C>T and IL-17F rs763780 T>C did not ( Table 2 ). The minor allele frequencies of IL-17A rs2275913G>A, rs3748067C>T, and IL-17F rs763780 T>C were similar to those in the dbSNP database (http://www.ncbi.nlm.nih.gov/SNP/).
By conditional regression analysis, individuals carrying the AA genotype and the GA+AA genotype of IL-17 rs2275913G>A were correlated with an elevated risk of GC when compared with those carrying the GG genotype, and the adjusted ORs (95%CIs) were 2.05 (1.13-3.76) for the AA genotype and 1.45 (1.03-2.08) for the GA+AA genotype (Table 3) . However, the IL-17A rs3748067C>T and IL-17F rs763780T>C gene polymorphisms were not associated with an increased risk of GC. members (IL-17A-F), which has an important function in connecting innate and adaptive immunities (Kolls and Lindén, 2004) . Previous studies have shown that IL-17 is an essential proinflammatory cytokine that evokes the production of many additional cytokines and chemokine secretion through various cell types such as mesenchymal and myeloid cells, in order to recruit monocytes and neutrophils into the microenvironment of the site of inflammation (Iwakura et al., 2011) . In addition, IL-17 plays important roles in promoting the expression of antimicrobial peptides and in facilitating host defense against infections (Kao et al., 2004; Matsuzaki and Umemura, 2007) . To date, many molecular epidemiological studies have evaluated the association between IL-17 gene polymorphisms and the development of GC, but the published results have been conflicting. For the association between IL-17A rs2275913G>A and the risk of GC, six studies reported different results (Shibata et al., 2009; Arisawa et al., 2012; Qinghai et al., 2014; Wang et al., 2014; Zhang et al., 2014; Gao et al., 2015) . Shibata et al. (2009) and Arisawa et al. (2012) reported that the A allele of IL-17A rs2275913G>A was significantly associated with the development of GC in Japanese populations. In addition, Zhang et al. (2014) conducted a casecontrol study in a Chinese population and reported that the IL-17A rs2275913G>A polymorphism increased GC risk, and interacted with H. pylori infection. Qinghai et al. (2014) and Wang et al. (2014) also conducted case-control studies in a Chinese population and suggested that the IL-17A rs2275913G>A polymorphism increased the risk of GC. However, the case-control study of Gao et al. (2015) , also in a Chinese population, did not find significant association between the IL-17A rs2275913G>A polymorphism and the risk of developing GC. In our study, we found that the AA and GA+AA genotypes of IL-17A rs2275913G>A were correlated with an elevated risk of GC. The discrepancies between these results might be caused by differences in ethnicities, study design, and sample size.
We identified three limitations in this study. First, patients and controls were selected from one hospital, and IL-17A rs3748067C>T and IL-17F rs763780 T>C were not in accordance with HWE in the control group, which suggests that the sample used by this study would not likely be representative of other populations. Second, the sample size of patients with GC was relatively small, which might limit the statistical power to find an association between groups. Third, the risk of GC might be modified by many other cytokine genes in addition to the IL-17 genes. Therefore, further studies with larger sample sizes are greatly needed to assess the association between IL-17 gene polymorphisms and the risk of GC.
In conclusion, our results suggest that the IL-17A rs3748067C>T and IL-17F rs763780 T>C polymorphisms play an important role in the risk of GC in a Chinese population. Further studies involving various populations and large sample sizes are greatly needed to confirm our results.
